Overview

A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Study of the Safety, tolerability and pharmacokinetics with single dose of donepezil patch in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Icure Pharmaceutical Inc.
Treatments:
Donepezil